blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1448200

EP1448200 - (4-PHENYL)PIPERIDIN-3-YL-PHENYLCARBOXYLATE DERIVATIVES AND RELATED COMPOUNDS AS BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  20.02.2009
Database last updated on 05.10.2024
Most recent event   Tooltip20.02.2009Application deemed to be withdrawnpublished on 25.03.2009  [2009/13]
Applicant(s)For all designated states
ELAN PHARMACEUTICALS, INC.
800 Gateway Boulevard
South San Francisco, CA 94080 / US
For all designated states
Pharmacia & Upjohn Company LLC
7000 Portage Road
Kalamazoo, MI 49001 / US
[N/P]
Former [2007/04]For all designated states
Elan Pharmaceuticals, Inc.
800 Gateway Boulevard
South San Francisco, CA 94080 / US
For all designated states
Pharmacia & Upjohn Company LLC
7000 Portage Road
Kalamazoo, MI 49001 / US
Former [2005/22]For all designated states
Elan Pharmaceuticals, Inc.
800 Gateway Boulevard
South San Francisco, CA 94080 / US
For all designated states
Pharmacia & Upjohn Company LLC
301 Henrietta Street
Kalamazoo, MI 49001 / US
Former [2004/35]For all designated states
Elan Pharmaceuticals, Inc.
800 Gateway Boulevard
South San Francisco, CA 94080 / US
For all designated states
Pharmacia & Upjohn Company
301 Henrietta Street
Kalamazoo, MI 49007 / US
Inventor(s)01 / JOHN, Varghese
1722 - 18th Avenue
San Francisco, CA 94122 / US
02 / MOON, Joseph, B.
2203 Sheffield Drive
Kalamazoo, MI 49008 / US
03 / PULLEY, Shon, R.
13850 Kellogg School Road
Hickory Corners, MI 49060 / US
04 / RICH, Daniel, H.
2978 Woods Edge Way
Madison, WI 53711 / US
05 / BROWN, David, L.
15504 Twingate
Chesterfield, MO 63017 / US
06 / JAGODZINSKA, Barbara
1485 Kentfield Avenue
Redwood City, CA 94061 / US
07 / JACOBS, Jon, S.
103 Merriweather Lane
Kalamazoo, MI 49006 / US
 [2004/35]
Representative(s)Nargolwalla, Cyra
Cabinet Plasseraud
ATTENTION : ADDRESS INACTIVE - USE ASS-NR - CDR
Paris / FR
[N/P]
Former [2008/35]Nargolwalla, Cyra
Cabinet Plasseraud 52 rue de la Victoire
75440 Paris Cedex 09 / FR
Former [2004/35]Nargolwalla, Cyra
Cabinet Plasseraud, 65/67 rue de la Victoire
75009 Paris Cedex 09 / FR
Application number, filing date02795653.119.11.2002
[2004/35]
WO2002US37037
Priority number, dateUS20010332708P19.11.2001         Original published format: US 332708 P
US20020383167P24.05.2002         Original published format: US 383167 P
[2004/35]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO03043987
Date:30.05.2003
Language:EN
[2003/22]
Type: A2 Application without search report 
No.:EP1448200
Date:25.08.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 30.05.2003 takes the place of the publication of the European patent application.
[2004/35]
Search report(s)International search report - published on:EP10.07.2003
ClassificationIPC:A61K31/451, C07D211/42, C07D407/04, C07D413/04
[2004/35]
CPC:
C07D401/04 (EP,US); C07D405/04 (EP,KR,US); A61K31/451 (KR);
A61P25/14 (EP); A61P25/28 (EP); A61P43/00 (EP);
A61P9/10 (EP); C07D211/40 (EP,US); C07D211/42 (EP,US);
C07D401/12 (EP,US); C07D409/12 (EP,US); C07D409/14 (EP,US);
C07D413/04 (KR) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   SK,   TR [2004/35]
Extension statesAL01.06.2004
LT01.06.2004
LV01.06.2004
MK01.06.2004
RO01.06.2004
SI01.06.2004
TitleGerman:DERIVATE DES (4-PHENYL)PIPERIDIN-3-YL-PHENYLCARBOXYLATS UND VERWANDTE VERBINDUNGEN ALS BETA-SECRETASE INHIBITOREN ZUR BEHANDLUNG VON ALZHEIMER[2004/35]
English:(4-PHENYL)PIPERIDIN-3-YL-PHENYLCARBOXYLATE DERIVATIVES AND RELATED COMPOUNDS AS BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE[2004/35]
French:PIPERIDINES ET PIPERAZINES 3,4-DISUBSTITUEES, 3,5-DISUBSTITUEES ET 3,4,5-SUBSTITUEES[2004/35]
Entry into regional phase01.06.2004National basic fee paid 
01.06.2004Designation fee(s) paid 
01.06.2004Examination fee paid 
Examination procedure17.06.2003Request for preliminary examination filed
International Preliminary Examining Authority: US
01.06.2004Examination requested  [2004/35]
08.07.2004Amendment by applicant (claims and/or description)
24.04.2007Despatch of a communication from the examining division (Time limit: M06)
16.10.2007Reply to a communication from the examining division
16.05.2008Despatch of a communication from the examining division (Time limit: M04)
27.09.2008Application deemed to be withdrawn, date of legal effect  [2009/13]
04.11.2008Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2009/13]
Fees paidRenewal fee
22.11.2004Renewal fee patent year 03
29.11.2005Renewal fee patent year 04
27.11.2006Renewal fee patent year 05
27.11.2007Renewal fee patent year 06
Penalty fee
Additional fee for renewal fee
30.11.200807   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]US4745122  (LASSEN JOERGEN B [DK]) [X] 1-33,35-58 * column 1, line 7 - line 9 *;
 [X]EP0296721  (LUNDBECK & CO AS H [DK]) [X] 1-58 * page 3, line 37; example -; claim - *;
 [X]EP0316718  (FERROSAN AS [DK]) [X] 1-58 * page 3, paragraph 1 * * compounds of formulae (I) and (II) *;
 [X]WO9709311  (HOFFMANN LA ROCHE [CH]) [X] 1-33,35-58 * example -; claim - *;
 [X]WO9912532  (HOFFMANN LA ROCHE [CH], et al) [X] 1-33,35-58 * example -; claim - *;
 [X]EP0979819  (HOFFMANN LA ROCHE [CH]) [X] 1-33,35-58 * example 7 *;
 [X]WO0020390  (UNIV GEORGETOWN [US]) [X] 1-58 * page 6, line 1 * * example -; claim - *;
 [PX]WO02066469  (AVENTIS PHARMA INC [US], et al) [PX] 1-58* page 26, line 35; examples 2,3 *;
 [PX]WO02076440  (ELAN PHARM INC [US], et al) [PX] 1-58 * page 1, paragraph 2; example -; claim - *;
 [PX]WO02088101  (VERTEX PHARMA [US], et al) [PX] 1-58 * page 1, paragraph 1; example -; claim - *;
 [X]  - BURSAVICH, MATTHEW G. ET AL, "Solid-Phase Synthesis of Aspartic Peptidase Inhibitors: 3-Alkoxy-4-Aryl Piperidines", CA, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, Database accession no. 135:226867, URL: STN, XP002237590 [X] 1-33,36-58 * abstract *
    [ ] - ORGANIC LETTERS (2001), 3(17), 2625-2628
 [X]  - VIEIRA, ERIC ET AL, "Substituted piperidines - highly potent renin inhibitors due to induced fit adaptation of the active site", CA, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, Database accession no. 131:102177, URL: STN, XP002237591 [X] 1-33,38-58 * abstract *
    [ ] - BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (1999), 9(10), 1397-1402
 [X]  - BURSAVICH, MATTHEW G. ET AL, "From Peptides to Non-Peptide Peptidomimetics: Design and Synthesis of New Piperidine Inhibitors of Aspartic Peptidases", CA, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, Database accession no. 135:210920, URL: STN, XP002237592 [X] 1-33,35-58 * abstract *
    [ ] - ORGANIC LETTERS (2001), 3(15), 2317-2320
 [X]  - OEFNER, C. ET AL, "Renin inhibition by substituted piperidines: a novel paradigm for the inhibition of monomeric aspartic proteinases?", CA, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, Database accession no. 131:2120, URL: STN, XP002237593 [X] 1-33,35-58 * abstract *
    [ ] - CHEMISTRY & BIOLOGY (1999), 6(3), 127-131
 [X]  - MCERLANE K M J ET AL, "STEREOCHEMISTRY OF 3-METHYL-4-PHENYLPIPERIDINES DERIVED FROM CORRESPONDING 4-PHENYL-4-PIPERIDINOLS", CANADIAN JOURNAL OF CHEMISTRY, NATIONAL RESEARCH COUNCIL. OTTAWA, CA, (1972), vol. 50, no. 13, ISSN 0008-4042, pages 2149 - 2151, XP000995803 [X] 1-33,35-58 * example 2C *

DOI:   http://dx.doi.org/10.1139/v72-345
 [X]  - ROGERS G A ET AL, "THE MOST INTERESTING MEMBERS OF THE AH5183 FAMILY OF DRUGS", CELLULAR AND MOLECULAR BASIS OF COLINERGIC FUNCTION, XX, XX, (1987), pages 333 - 337, XP001056296 [X] 1-33,35-58 * example 13 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.